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ORIGINAL ARTICLE
Primary care practice-based care management for chronically ill patients
(PraCMan) in German healthcare: Outcome of a propensity-score matched
cohort study
Jonas D. Senft, Tobias Freund, Michel Wensing, Simon Schwill , Regina Poss-Doering, Joachim Szecsenyi
and Gunter Laux
Department of General Practice and Health Services Research, University Hospital Heidelberg, Heidelberg, Germany
KEY MESSAGES
 Primary Care Practice-Based Care Management (PraCMan) is a disease management intervention for chron-
ically ill patients aiming to avoid unnecessary hospitalisations.
 A retrospective propensity-matched cohort study was performed to evaluate its efficacy.
 Participation in PraCMan may be associated with a lower of hospital admission rate and costs than
usual care.
ABSTRACT
Background: Growing prevalence of chronic diseases is a rising challenge for healthcare sys-
tems. The Primary Care Practice-Based Care Management (PraCMan) programme is a compre-
hensive disease management intervention in primary care in Germany aiming to improve
medical care and to reduce potentially avoidable hospitalisations for chronically ill patients.
Objectives: This study aimed to assess the effect of PraCMan on hospitalisation rate and
related costs.
Methods: A retrospective propensity-score matched cohort study was performed.
Reimbursement data related to patients treated in general practices between 1st July 2013 and
31st December 2017 were supplied by a statutory health insurance company (AOK Baden-
Wuerttemberg, Germany) to compare hospitalisation rate and direct healthcare costs between
patients participating in the PraCMan intervention and propensity-score matched controls fol-
lowing usual care. Outcomes were determined for the one-year-periods before and 12months
after beginning of participation in the intervention.
Results: In total, 6148 patients participated in the PraCMan intervention during the observation
period and were compared to a propensity-score matched control group of 6148 patients from
a pool of 63,446 eligible patients. In the one-year period after the intervention, the per-patient
hospitalisation rate was 8.3% lower in the intervention group compared to control (p¼ 0.0004).
Per-patient hospitalisation costs were 9.4% lower in favour of the intervention
group (p¼ 0.0002).
Conclusion: This study showed that the PraCMan intervention may be associated with a lower
rate of hospital admissions and hospitalisation costs than usual care. Further studies may assess
long-term effects of PraCMan and its efficacy in preventing known complications of
chronic diseases.
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Growing prevalence of chronic diseases is a major
challenge for healthcare systems. Physicians face
increasing numbers of patients with complex health-
care needs while average consultation time in primary
care is limited to less than 10min in many countries
[1]. This may eventually affect the quality of medical
care of chronic conditions since improper manage-
ment of, e.g. asthma exacerbations or wound healing
disorders in diabetic patients may lead to adverse
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outcomes, potentially avoidable hospitalisation and
increased healthcare costs [2].
In recent decades, various strategies have been
developed to maintain access to high-quality primary
care. Non-physician health workers like nurse practi-
tioners in the US and Australia, licenced nurses in
Denmark and The Netherlands, and certified health-
care assistants in Germany (‘Versorgungsassistent/in
der Hausarztpraxis,’ VERAH) have been increasingly
involved in patient care [3–6]. Nurse-led programmes
have been developed to treat common consultations
like gout flares or osteoarthritis [7,8] and complex dis-
ease management interventions have been developed
to treat chronic health conditions [9–11].
The Primary Care Practice-Based Care Management
(PraCMan) programme is a large-scale disease man-
agement intervention for chronically ill patients, which
was introduced in Germany to improve medical care
and reduce avoidable hospitalisations in the primary
care setting [12]. Patients with chronic heart failure
(CHF), type 2 diabetes (T2DM) or chronic obstructive
pulmonary disease (COPD) who are at high risk for
hospitalisation, can participate in this scripted inter-
vention provided by specifically trained medical assis-
tants under general practitioners’ (GP) guidance. Soon
after establishment, the efficacy of PraCMan was ana-
lysed in an RCT including 115 general practices and
2076 patients [13]. No effect was shown on all-cause
hospitalisations at 24months. Nevertheless, quality of
life and general health improved, indicating that the
intervention may have a beneficial health effect.
To date, there is only limited knowledge about the effi-
cacy of comprehensive interventions addressing multiple
chronic index conditions. Subsequent to the PraCMan
trial, the intervention was introduced into routine primary
care in the federal state of Baden-W€urttemberg. High vol-
ume secondary data were analysed in this cohort study
to reassess potential effects of the PraCMan intervention
on the need for hospitalisation and its direct healthcare
costs in the routine primary care setting.
Methods
Study design
A retrospective propensity-matched cohort study was
performed. Data related to patients treated in general
practices between 1st July 2013 and 31st December
2017 were supplied by a statutory health insurer (AOK,
Baden-Wuerttemberg, Germany) to compare hospital-
isation rate and costs between patients participating
in the PraCMan intervention and matched patients fol-
lowing usual care.
Ethics
Ethical approval was given by the local institutional
Ethics Committee of the University Hospital
Heidelberg (No. S-359/2013).
Study population
The AOK is the largest statutory health insurer of the
federal state of Baden-Wuerttemberg, covering nearly
4 million inhabitants. Secondary data related to
patients participating in a GP-centred care programme
(German: ‘Hausarztzentrierte Versorgung’ (HZV)) were
eligible for data analysis. The HZV programme is a
large-scale, legally stipulated health plan aiming to
strengthen outpatient care by encouraging patients to
enrol with a GP [14]. Secondary patient data was
included in this analysis according to the following cri-
teria: age 18 years or older, at least one visit to the pri-
mary care physician in the relevant year, continuous
registration to HZV program. Patients were excluded if
they were also registered in other primary care con-
tracts (e.g. integrated care contracts). Patients partici-
pating in PraCMan (cases) were compared with
patients not participating in PraCMan (controls).
Intervention
PraCMan is a collaborative case management interven-
tion aiming to strengthen outpatient care for chronic-
ally ill patients and reduce avoidable hospitalisations
[12,13,15]. Practices participating in the HZV pro-
gramme can enrol to PraCMan after completing a 36-
h training course for medical assistants and installating
the PraCMan software. Reimbursement for practices is
given by 80eper quarter for each participating patient.
Patients with CHF, T2DM or COPD participating in the
HZV program may enrol to PraCMan if their predicted
likelihood for hospital admission (LOH) is within the
upper quartile of health plan patients [12,15]. The LOH
is routinely assessed by the AOK using a validated pre-
diction algorithm for analysis of demographic data,
ICD-10 diagnoses, healthcare costs and hospital admis-
sions within the preceding 18months [16,17].
The PraCMan intervention is provided by medical
assistants under GP-guidance and comprises three
major elements [12]:
1. Assessment is performed by medical assistants
using a standardised software protocol to record
a comprehensive medical status. The GP and med-
ical assistant discuss the results to identify the
patient’s individual care needs. Individual
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treatment targets are determined in discussion
and agreement between patients and caregivers.
Patients receive a folder comprising a list of
agreed individual treatment targets, disease-spe-
cific information leaflets, symptom diaries, action
plans for self-management, medical reports,
laboratory results and medication lists.
2. Monitoring is provided by medical assistants via
regular telephone follow-up. Standardised moni-
toring items such as symptom scores and labora-
tory analyses are recorded and evaluated using
the PraCMan software to assess the risk for deteri-
oration of health status and the urgency of re-
evaluation. Content and interval of follow-ups are
decided on an individual basis for each patient
via consultation between patient, medical assist-
ant and GP.
3. Training of caregivers is provided to ensure inter-
vention quality. After a mandatory 36-h introduc-
tion training (20 h self-study, 16 h interactive
workshop) for medical assistants, practice teams
receive yearly 8-h-workshops for training of the
PraCMan intervention and communication techni-
ques according to a standardised curriculum.
Data acquisition and outcome parameters
Secondary patient data recorded for reimbursement
purposes by the AOK was pseudonymised and sup-
plied to the Department of General Practice and
Health Services Research, University Hospital
Heidelberg. Data storage and extraction was per-
formed with MySQL Community Server x64 (Oracle
Corporation, Redwood Shores, CA, USA). All national
and institutional guidelines concerning data acquisi-
tion for retrospective analyses were followed.
The obtained data set comprised age, gender, diag-
noses according to ICD-10, nursing care level and
accounting data on hospital stays. The nursing care
level rates the individual need for nursing care on an
integral scale of one (minor impairment) to five
(severe impairment) and is determined on assessment
by the Medical Control Service (German:
‘Medizinischer Kontrolldienst’), an independent and
governmentally supervised institution. Patients’ overall
morbidity was assessed by the Charlson index, which
was determined by diagnoses according to ICD-10
[18]. Number of hospital admissions and costs for hos-
pitalisation in ewere determined by the recorded
Diagnosis Related Groups (DRG) codes used for reim-
bursement of inpatient medical services in Germany.
For each patient the outcomes were determined for
the one-year-periods before and 12months after
beginning of participation in the intervention. The
observation periods are displayed in Figure 1.
Statistical analysis
Propensity-score matching was performed using
according to Rosenbaum and Rubin [19] using the fol-
lowing matching variables: age, gender, Charlson
index, nursing care level, index condition and LOH.
The package ‘Matching’ [20], running R Version
3.5.3 64, was used for the matching procedure.
Controls were matched using ‘1:1 nearest-neighbour
matching.’ This means that for each case individual i
one control individual with the smallest ‘distance’
from individual i is selected. In our context, the dis-
tance is given by the propensity score. Both, cases
and controls were recruited from the PraCMan pro-
posal list (German: Vorschlagsliste). This list is based
on an algorithm to determine high risk for hospitalisa-
tion according to LOH (please see ‘Intervention’ sec-
tion). For evaluation of the matching results, the
‘MatchBalance’ function of this package was applied.
This function cheques the quality of the matching for
each matching variable. Depending on the scaling of
the particular variable, proportions, means, and distri-
butions were checked. We additionally calculated
standardised differences for each matching variable to
assess the balance between cases and matched con-
trols. Cases and controls with death during the obser-
vation time were not included in the analysis. To
calculate frequencies, rates and percentages, we used
SAS PROC SQL (SAS V.9.4 64, SAS Institute). The R’s
package ‘rateratio’ was used to calculate the risk ratios
Figure 1. Observation periods.
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for the event ‘hospitalisation.’ The method
‘rateratio.test’ performs exact rate ratio tests based on
Poisson counts and additionally calculates p-values
and confidence intervals. For univariable nonparamet-
ric comparisons of matched cases and controls, we
used R’s function ‘wilcox.test’ (Wilcoxon test).
Pearson’s chi-squared test was used to compare fre-
quencies. For all analyses, results were considered stat-
istically significant if the p value was 0.05 or less.
Results
In total, 6148 patients participated in the PraCMan inter-
vention during the observation period. According to pro-
pensity score matching, 6148 matched controls were
selected from a pool of 63,446 patients not participating
in the PraCMan intervention. Table 1 shows the patient
characteristics of intervention and matched control
group. There were no differences between cases and
matched controls for any patient characteristic.
In the one-year period before intervention began the
per-patient hospitalisation rate was 3.5% higher for
patients in the intervention group compared to control
(p< 0.05). In the one-year period 12months after begin-
ning of the intervention the per-patient hospitalisation
rate was 8.3% lower in the intervention group than con-
trol (p< 0.001). Per-patient hospitalisation costs in the
pre-interventional period were 3.1% higher for patients in
the intervention group compared to control (p: n.s.). In
the observation period after beginning of the intervention
per-patient hospitalisation costs were 9.4% lower in
favour of the intervention group (p< 0.001). Average per-
patient hospitalisation rates and costs for the observation
periods are shown in Tables 2 and 3. The ‘Difference in
Differences’ shows the difference between cases and con-
trols regarding their particular change from the year
before intervention to the year after intervention. In 2017,
we had an overall average hospitalisation rate of 0.287
and average hospitalisation costs of 1243eper patient par-
ticipating in the specific primary care-centred programme
(‘Hausarztzentrierte Versorgung,’ HZV) for N¼ 1,037,093
patients. No significant difference was found with regard
to the mortality rate at the end of the one-year observa-
tion period (cases: 11.87%, controls: 11.88%, p: n.s.).
Discussion
Main findings
This is the first study to assess the effectiveness of a
large-scale primary care disease management
Table 1. Patient characteristics.
PraCMan Matched controls Standardised difference
Number of patients 6148 6148
Malea (n; %) 3394 (55.2%) 3443 (56.0%) 0.016
Agea (mean ± SD) 75.6 ± 9.8 75.5 ± 9.8 0.009
Need for nursing carea (n; %) 910 (14.8%) 900 (14.6%) 0.007
Charlson indexa 0.018
Mean; 95%-CI 4.57; [4.51, 4.64] 4.53; [4.47; 4.59]
Median; 25% perc.; 75% perc. 4.0; 3.0; 6.0 4.0; 3.0; 6.0
Chronic index condition
CHFa (n; %) 4679 (76.1%) 4666 (75.9%) 0.003
T2DMa (n; %) 3277 (53.3%) 3240 (52.7%) 0.012
COPDa (n; %) 2803 (45.6%) 2779 (45.2%) 0.008
aDifference of percentage or mean: not significant.
CHF: chronic heart failure; COPD: chronic obstructive pulmonary disease; T2DM: type 2 diabetes mellitus.
Table 2. Average patient hospitalisation rates.
Year before intervention Year after intervention
PraCMan
Mean [95%-CI] 1.112 [1.078; 1.146] 0.787 [0.754; 0.820]
Median; 25% Perc.; 75% Perc. 1.0; 0.0; 2.0 0.0; 0.0; 1.0
Matched Controls
Mean [95%-CI] 1.074 [1.041; 1.107] 0.858 [0.824; 0.892]
Median; 25% Perc.; 75% Perc. 1.0; 0.0; 2.0 0.0; 0.0; 1.0
Risk Ratio
(PraCMan vs. Controls)
RR [95%-CI] 1.035 [1.001; 1.071] 0.917 [0.882; 0.954]
p< 0.05 p< 0.001
Reduction of hospitalisations
(DID: DPraCMan–DControls)
Mean; 95%-CI 0.1090; [0.1688; 0.0491]
Median; 25% Perc.; 75% Perc. 0.0; 1.0; 1.0
p< 0.001
CI: confidence interval; DID: differences-in-differences; Perc.: percentile.
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intervention for chronically ill patients in Germany
using high-volume reimbursement data. The analysis
of secondary data from 12,296 patients showed that
participation in the PraCMan programme is associated
with a lower rate of all-cause hospitalisations and
lower hospitalisation costs compared to matched con-
trols at the end of the one-year observation period.
Interpretation of results
The effectiveness of disease management in reducing
all-cause hospitalisations has already been shown in
previous research, most notably in patients with CHF
[11,22,23]. With regard to T2DM, there is firm evidence
that disease management interventions improve gly-
caemic control [24–26]. For COPD, study results assess-
ing efficacy of disease management are conflicting
[9,27]. The results of this analysis suggest that the
PracMan programme may be an effective approach to
prevent avoidable hospitalisations. Avoiding unneces-
sary hospitalisation may help to reduce the large bur-
den of medical treatment, particularly for patients
with multiple chronic conditions. Reduction of hospi-
talisations and costs was also observed in the control
group. This can be explained by the regression
towards the mean phenomenon since due to match-
ing, controls had a high rate of hospitalisations in the
first year before intervention, which naturally
decreased at the end of the observation period. In
contrast to known disease management approaches
focussing on single interventions for a specific chronic
condition, PraCMan unites multiple interventions to a
comprehensive care concept addressing CHF, T2DM
and COPD. We postulate that three characteristics con-
tribute to its effectiveness: (1) PraCMan unites standar-
dised patient assessment, individualised case
management and monitoring as well as continuous
training of caregivers to one comprehensive care con-
cept. (2) PraCMan allows treatment of several chronic
conditions by one standardised approach. (3) PraCMan
was designed to strengthen primary care, which may
be the most effective mainstay for treating patients
with chronic conditions, since individual medical and
non-medical patient needs are best known by treating
GPs and their teams.
Avoidable hospitalisation will be a driving cost fac-
tor for health care systems, which will be challenged
by the rising prevalence of chronic diseases in the
future [2,21]. Until today, disease management inven-
tions have not been proven to be cost-effective.
Findings of this analysis indicate an average reduction
of hospitalisation costs per year of 483eper patient
participating in PraCMan. Whether the administrative
effort of practices is compensated by financial reim-
bursement of 80eper quarter and patient may not be
answered by this analysis. However, long-term partici-
pation of GP practices may be seen as a potential indi-
cator of adequate compensation. At the same time,
the patient-sided benefits of avoiding hospitalisation
and improved quality of life, as shown by the
PraCMan trial, need to be emphasised [13].
Strength and limitations
To our knowledge, this is the first study indicating
that a comprehensive disease management pro-
gramme for multiple chronic conditions in routine pri-
mary care has a beneficial effect on the rate of
hospital admissions and hospitalisation costs. We con-
ducted a reimbursement data analysis due to its high
number of cases and statistical power, allowing inclu-
sion of secondary data from 12,296 patients.
Nevertheless, limitations to this study are given by its
retrospective design and the nature of reimbursement
data. Even if our matching was excellent for the
observed covariables, we could not control for poten-
tially relevant unobserved confounders, such as socio-
economic variables, which were not available.
Table 3. Average patient hospitalisation costs in e.
Year before intervention Year after intervention
PraCMan
Mean [95%-CI] 4570 [4348; 4792] 3315 [3114; 3516]
Median; 25% Perc.; 75% Perc. 2031.46; 0.0; 5794.03 0.0; 0.00; 3371.46
Matched Controls
Mean [95%-CI] 4431 [4229; 4633] 3659 [3459; 3859]
Median; 25% Perc.; 75% Perc. 1811.03; 0.00; 5592.84 0.00; 0.00; 4133.72
Reduction of costs
(DID: DPraCMan–DControls)
Mean; 95%-CI 482.66 [865.02, 100.30])
Median; 25% Perc.; 75% Perc. 5700.04; 0.00; 4884.19
p< 0.001
CI: confidence interval; DID: differences-in-differences; Perc.: percentile.
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Furthermore, taking part in the PraCMan intervention
is an ‘add on’ to the HZV programme; therefore, it is
possible that some matched controls actively refused
to additionally take part in PraCMan, which may be a
potential source of selection bias. Due to eligibility cri-
teria, patients are at high risk for hospitalisation at the
beginning of the intervention and the effect of avoid-
ing hospitalisation is presumably the highest within
the first year. No conclusion can be drawn regarding
long-term effects of PraCMan since the provided data
limited the follow-up to one year. It is unclear if the
intervention may also be suitable for patients with less
severe chronic index conditions. Future prospective
studies may address these aspects.
Conclusion
This large cohort study in a primary care setting
showed that the PraCMan intervention may be associ-
ated with a lower rate of all-cause hospital admissions
and hospitalisation costs compared to usual care.
Further studies may assess long-term effects of
PraCMan and its efficacy in preventing known compli-
cations of chronic diseases. Large-scale implementa-
tion of PraCMan in primary care settings may be
considered for chronically ill patients after its adequate
evaluation in future RCTs.
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